Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 3 3

Status

Completed 3Unknown 1

Sponsor Class

NETWORK 3OTHER 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Carcinoma, Non-Small-Cell Lung 230Squamous Cell Carcinoma of Head and Neck 139Head and Neck Neoplasms 131Lung Neoplasms 117Esophageal Neoplasms 88Stomach Neoplasms 84Uterine Cervical Neoplasms 68Esophageal Squamous Cell Carcinoma 66Urinary Bladder Neoplasms 59Breast Neoplasms 55Nasopharyngeal Carcinoma 51Small Cell Lung Carcinoma 46Carcinoma, Squamous Cell 39Neoplasm Metastasis 38Pancreatic Neoplasms 36Neoplasms 35Biliary Tract Neoplasms 34Oropharyngeal Neoplasms 32Cholangiocarcinoma 32Ovarian Neoplasms 30Mesothelioma, Malignant 28Adenocarcinoma Of Esophagus 28Lymphoma 25Carcinoma 24Adenocarcinoma of Lung 24Central Nervous System Neoplasms 22Laryngeal Neoplasms 20Carcinoma, Ovarian Epithelial 20Recurrence 19Lymphoma, Large B-Cell, Diffuse 19

Interventions

Fluorouracil 6Cisplatin 4Radiotherapy, Intensity-Modulated 3Radiotherapy 3Magnetic Resonance Spectroscopy 3Capecitabine 3dehydroftorafur 2Specimen Handling 2Mitomycin 2Cetuximab 2toripalimab 1rocakinogene sifuplasmid 1pembrolizumab 1durvalumab 1atezolizumab 1Vaccines 1VGX-3100 1Taxes 1Radiosurgery 1Radiation 1Platinum 1Paclitaxel 1Nivolumab 1Mitozytrex 1Mitomycins 1MEDI0457 1Ipilimumab 1Immunoglobulin G 1Fluorodeoxyglucose F18 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Anal Canal Carcinoma × Cisplatin × Clear all
NCT00324415 2025-05-30

Combined Modality Therapy for Patients With With HIV and Stage I, Stage II, or Stage III Anal Cancer

AIDS Malignancy Consortium

Phase 2 Completed
45 enrolled 17 charts
Gastrointestinal

Anal Canal Carcinoma, Anus Neoplasms

NCT00316888 2023-06-29

Cetuximab, Cisplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Anal Cancer

Eastern Cooperative Oncology Group

Phase 2 Completed
63 enrolled 10 charts
Gastrointestinal

Anal Canal Carcinoma, Anus Neoplasms

NCT02560298 2023-06-22

InterAACT

Eastern Cooperative Oncology Group

Phase 2 Unknown
91 enrolled
Gastrointestinal

Anal Canal Carcinoma, Anus Neoplasms

NCT02402842 2022-05-16

Epitopes-HPV02

Centre Hospitalier Universitaire de Besancon

Phase 2 Completed
70 enrolled
Gastrointestinal

Anal Canal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡